Company performance
Add to research
Current Price
as of Feb 07, 2025$16.19
P/E Ratio
N/A
Market Cap
$438.54M
Description
Add to research
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerARCT
- Price$16.19-6.36%
Trading Information
- Market cap$438.54M
- Float90.68%
- Average Daily Volume (1m)381,468
- Average Daily Volume (3m)428,422
- EPS-$2.21
Company
- Revenue$145.60M
- Rev growth (1yr)-10.52%
- Net income-$6.90M
- Gross margin97.68%
- EBITDA margin-1.70%
- EBITDA-$0.66M
- EV$365.35M
- EV/Revenue2.51
- P/EN/A
- P/S3.01
- P/B1.67
- Debt/Equity11.24
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset